Taiwan FDA registration 751dcf6d172a12f4aed656810e9e70c7
Cutting-edge medical cannabis rapid test reagents
TW: 尖端醫 大麻快速檢驗試劑
Taiwan·Risk Class 2·Formosa Biomedical Technology Co., Ltd. Yilan Factory·Registered Oct 03, 2018 – Nov 04, 2028ActiveRegistration details
- Analysis ID
- 751dcf6d172a12f4aed656810e9e70c7
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIWAN ADVANCE BIO-PHARMACEUTICAL INC.
Product details
- Intended Use
- This product uses competitive immunochromatography to qualitatively detect cannabis in human urine, and the test results can be used for preliminary screening. The cannabis threshold standard is set to 50ng/ml. This product can be used by both individuals and professionals.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.3870 Cannabis Trial System
- Import Information
- Contract manufacturing;; Domestic
Dates and status
- Registration Date
- Oct 03, 2018
- Expiry Date
- Nov 04, 2028
About this record
Access comprehensive regulatory information for Cutting-edge medical cannabis rapid test reagents in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 751dcf6d172a12f4aed656810e9e70c7 and manufactured by Formosa Biomedical Technology Co., Ltd. Yilan Factory. The authorized representative in Taiwan is TAIWAN ADVANCE BIO-PHARMACEUTICAL INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices